EUVIMEDEUVIMED entdecken
Crossref

Will GNRH antagonists be worth the wait?

Keith Gordon, Gary D Hodgen

Reproductive Medicine Review · 1992

DOI: 10.1017/s0962279900000533 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reproductive Medicine Review, 1992. Verfasst von Keith Gordon und 1 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gonadotropin-releasing hormone (GnRH) is also known as luteinizing hormone-releasing hormone (LHRH), formerly luteinizing hormone releasing factor (LRF). Since this hormone regulates the secretion of both FSH and LH, we prefer to call it GnRH. GnRH antagonists, as the name implies, are a class of compounds that actively compete with GnRH for the GnRH receptor, thereby neutralizing the effects of GnRH by competitive receptor occupancy. In order to fully appreciate their potential clinical utility, it is first important to comprehend the critical role of GnRH in the regulation of the pituitary-gonadal axis and secondly to familiarize ourselves with the mechanisms of action of GnRH, GnRH agonists and GnRH antagonists.

Zitieren

APA

Gordon, K., & Hodgen, G. D. (1992). Will GNRH antagonists be worth the wait?. Reproductive Medicine Review. https://doi.org/10.1017/s0962279900000533

Vancouver

Gordon K, Hodgen GD. Will GNRH antagonists be worth the wait?. Reproductive Medicine Review. 1992. doi:10.1017/s0962279900000533

BibTeX
@article{Gordon1992,
  author = {Gordon, Keith and Hodgen, Gary D},
  title = {Will GNRH antagonists be worth the wait?},
  journal = {Reproductive Medicine Review},
  year = {1992},
  doi = {10.1017/s0962279900000533}
}
Kostenlos starten →